Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
06/2003
06/19/2003US20030113380 Microparticles comprising polymeric binder and injection vehicle, wherein microparticles are suspended in vehicle at concentration of greater than 30 mg/ml to form suspension having viscosity of 600 cp at 20 degrees C
06/19/2003US20030113377 Orally administered liquid compositions
06/19/2003US20030113376 Omeprazole formulation
06/19/2003US20030113375 Pharmaceutical formulation and process
06/19/2003US20030113374 Mixture of two types of beads comprising a histamine H2 receptor antagonist, immediate release beads and timed pulsatile release beads; treatment of asthma, gastric acid secretion and cardiovascular diseases
06/19/2003US20030113373 Delivery of multiple doses of medications
06/19/2003US20030113372 Analgesic in admixture with injectable oil; nalbuphine free base or a pharmaceutically acceptable salt
06/19/2003US20030113371 Composition and method for maintaining blood glucose level by employing the hydrophilic matrix based oral controlled release antidiabetic composition
06/19/2003US20030113370 Method for enabling delivery of an active agent
06/19/2003US20030113369 Liposomes with enhanced circulation time and method of treatment
06/19/2003US20030113368 Holding capability for hydrophilic and lipophilic drugs, water-soluble and hydrophobic substaces; controlling sustained release
06/19/2003US20030113366 Reverse-micellar delivery system for controlled transportation and enhanced absorption of agents
06/19/2003US20030113365 Copolymer of alkyl (meth)acrylate and pyrrolidonoethyl (meth)acrylate; transdermal drug delivery device
06/19/2003US20030113359 Prosthetic device placed on the outside surface of the vessel or graft which then elutes antiproliferatives from a matrix
06/19/2003US20030113355 Nontoxic vernix compositions and method of producing
06/19/2003US20030113351 Lipid carrier
06/19/2003US20030113347 Immunostimulating and immunopotentiating reconstituted influenza virosomes and vaccines containing them
06/19/2003US20030113316 Stable lyophilized pharmaceutical formulation of IgG antibodies
06/19/2003US20030113298 Applying the lytic protein, peptides, or peptide fragments to the mucosal surface, produced by infecting a bacterium causing infection with a bacteriophage specific for the bacteria
06/19/2003US20030113290 Procyanidins as antineoplastic agents; topolisomerase, cylooxygenase, and/or lipoxygenase inhibitors; nitric oxide synthase modulators; hypotensive agents
06/19/2003US20030113278 Treatment of excessive radiation (e.g. sunburn) exposure
06/19/2003US20030113276 Flexible polybutene strips for preventing gingivitis/whitening of teeth
06/19/2003US20030113274 Comprises anionic and nonionic surfactants such as sodium stearate and sodium palmitate
06/19/2003US20030113273 Aerosolized dry powders for high speed absorption
06/19/2003US20030113272 Powders comprising anti-adherent materials for use in dry powder inhalers
06/19/2003US20030113269 Medical combinations comprising tiotropium and fluticasone proprionate
06/19/2003US20030113268 Degradation-resistant glucocorticosteroid formulations
06/19/2003CA2484528A1 Isoflavone composition for oral delivery
06/19/2003CA2471742A1 Method of producing a nicotine composition
06/19/2003CA2469770A1 Device for treating headache
06/19/2003CA2469718A1 Methods and products useful in the formation and isolation of microparticles
06/19/2003CA2469340A1 Treating muscle wasting with selective androgen receptor modulators
06/19/2003CA2467245A1 Prevention of flap necrosis in plastic surgery
06/19/2003CA2464341A1 Conductance of improperly folded proteins through the secretory pathway and related methods for treating disease
06/19/2003CA2461491A1 Methods of screening for antagonists of apm1/gzip
06/18/2003EP1319684A1 The preparation method of a stable polymer aqueous phase-aqueous phase emulsion and its use
06/18/2003EP1319670A1 Low-substituted hydroxypropyl cellulose
06/18/2003EP1319667A2 Solid phase method for the synthesis of peptide-spacer-lipid conjugates, conjugates synthesized thereby and targeted liposomes containing the same
06/18/2003EP1319644A1 Process for the preparation of directly compactible beta-mannitol
06/18/2003EP1319409A1 Solid preparations
06/18/2003EP1319407A1 Pharmaceutical composition for topical treatment of skin disorders and skin wounds
06/18/2003EP1319403A1 Remedies for cisplatin-tolerant cancer
06/18/2003EP1319401A1 Compositions for regulating desire for smoking
06/18/2003EP1319400A2 Process to generate submicron particles of water-insoluble compounds
06/18/2003EP1319399A1 Medicinal composition
06/18/2003EP1319397A1 Suppositories sustained in the lower rectum
06/18/2003EP1319025A2 Human antibodies against pseudomonas aeruginosa lps derived from transgenic xenomouse
06/18/2003EP1319014A1 Antisense modulation of flip-c expression
06/18/2003EP1318973A2 Novel alkanoic acid derivatives
06/18/2003EP1318843A2 Acryl adhesive useful in transdermal drug delivery systems
06/18/2003EP1318819A1 Treatment of trauma, and other indications
06/18/2003EP1318818A1 Diphosphonate solutions
06/18/2003EP1318813A1 Stable pergolide mesylate and process for making same
06/18/2003EP1318809A1 Micronized torsemide
06/18/2003EP1318808A1 Method of treating aquatic animals with an antimicrobial agent and chelating agent
06/18/2003EP1318807A1 Photosensitizing ointment
06/18/2003EP1318805A2 Pharmaceutical composition containing citalopram
06/18/2003EP1318801A2 Topical analgesic compositions containing aliphatic polyamines and methods of using same
06/18/2003EP1318799A2 Stable dosage forms containing ubiquinones
06/18/2003EP1318798A1 Water-soluble prodrugs of propofol for treatment of migraine
06/18/2003EP1318792A2 Sustained release composition containing clarithromycin
06/18/2003EP1318791A1 Pharmaceutical semi-solid composition of isotretinoin
06/18/2003EP1318790A1 Pharmaceutical compositions for rectal and vaginal administration
06/18/2003EP1318789A2 Method for granulation of active substances by low pressure extrusion to obtain directly compressible granules
06/18/2003EP1318788A1 Solid dose nanoparticulate compositions
06/18/2003EP1318787A2 Pharmaceutical suspension compositions lacking a polymeric suspending agent
06/18/2003EP1318786A2 Implantable drug delivery patch
06/18/2003EP1318785A2 Pulmonary delivery in treating disorders of the central nervous system
06/18/2003EP1318778A1 Treatment for high pressure bleeding
06/18/2003EP1318761A1 Concurrent tooth repositioning and substance delivery
06/18/2003EP1318721A1 Method of blocking free radical processes which result in mediated pathology without deleterious pro-oxidant side reactions
06/18/2003EP1275377B1 Granulates containing liposoluble substances and process of preparation thereof
06/18/2003EP1237585B1 Mineral-polymer hybrid composition
06/18/2003EP1225898B1 Pharmaceutical compositions containing a fluoroquinolone antibiotic drug and xanthan gum
06/18/2003EP1212095B1 Process to make a sustained release formulation
06/18/2003EP1200317B1 A device for spray dispensing a composition for topical application comprising vitamin e and essential fatty acids
06/18/2003EP1162951B1 Controlled release bupropion formulation
06/18/2003EP1009382B1 Oil in water emulsions containing saponins
06/18/2003EP0980376B1 Method for producing carbohydrate partial esters
06/18/2003EP0954287B1 Controlled release composition
06/18/2003EP0936902B1 Spray-dried microparticles as therapeutic vehicles for use in gene therapy
06/18/2003EP0904059B1 Improvement in the taste of active pharmaceutical ingredients
06/18/2003EP0868177B1 Drug delivery device
06/18/2003EP0759747B1 Transdermal device for administration through de-epithelialized skin
06/18/2003EP0650377B1 Neuroinhibitory compounds released by implanting devices
06/18/2003DE10145813C1 Odoriferous solution for suppressing appetite and alcohol and nicotine dependence, contains foul-smelling and superimposed sweet-smelling components dissolved in vehicle
06/18/2003CN1424926A Synergistic inhibition of viral replication long-chain hydrocarbons and nucleoside analogs
06/18/2003CN1424915A Oral, nasal and pulmonary dosage formulations of copolymer1
06/18/2003CN1424914A Carbon dioxide enhancement of inhalation therapy
06/18/2003CN1424909A Formulations for use in inhaler devices
06/18/2003CN1424908A Patch containing anti-inflammatory agent
06/18/2003CN1424907A Improved pharmaceutical formulations
06/18/2003CN1424906A Dosage forms having a barrier layer to laser ablation
06/18/2003CN1424903A Personal care articles comprising cationic polymer coacervate compositions
06/18/2003CN1424112A Water soluble dressing for insoluble medicines and preparation thereof
06/18/2003CN1424111A Hyacinth bletilla micro-balls for liver and kidney arterial embolism
06/18/2003CN1424096A Composite red sage root micro-capsules for cardio-cerebral diseases and its preparing method
06/18/2003CN1424094A Detumescence plaster
06/18/2003CN1424089A Composite red sage root spray for cardio-cerebral diseases and its preparing method
06/18/2003CN1424088A Composite red sage root granules for cardio-cerebral diseases and its preparing method
1 ... 2128 2129 2130 2131 2132 2133 2134 2135 2136 2137 2138 2139 2140 2141 2142 2143 2144 2145 2146 2147 2148 ... 2991